News - Pfizer, Vaccines

Filter

Current filters:

PfizerVaccines

Popular Filters

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s

25-02-2014

US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

Pfizer tasked with novel vaccine research by US government department

Pfizer tasked with novel vaccine research by US government department

12-12-2013

Pfizer, the world’s largest drugmaker by sales, has been awarded a nearly $7.7 million technology investment…

North AmericaPfizerPharmaceuticalResearchVaccines

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule

07-11-2013

A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

Updated EU labeling for Pfizer’s Prevenar 13

Updated EU labeling for Pfizer’s Prevenar 13

17-10-2013

The European Commission has approved updates to the Summary of Product Characteristics for US pharma…

EuropePfizerPharmaceuticalPrevenarRegulationVaccines

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Pfizer gets EU approval for Prevenar 13 for adults aged 18-49

10-07-2013

US drug giant Pfizer (NYSE: PFE) has today received European approval for an expanded indication of its…

EuropePfizerPharmaceuticalPrevenarRegulationVaccines

Adult vaccines market controlled by GSK and Merck

15-04-2013

The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen

07-01-2013

Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer…

BiotechnologyDekavilGlycoVaxynInflammatory diseasesJanssenJohnson & JohnsonLicensingPfizerPharmaceuticalPhilogenVaccines

Batch of mixed opinions from FDA advisory panels

21-06-2012

Advisory panels of the US Food and Drug Administration meeting yesterday came back with a mixture of…

carfilzomibKyprolisMerck & CoNorth AmericaOncologyOnyx PharmaceuticalsPfizerPharmaceuticalPneumovaxPrevnarRegulationSanofisemuloparinVaccines

Expanded use for Pfizer’s Prevnar 13

03-01-2012

Following a previous US Food and Drug Administration advisory panel recommendation (The Pharma Letter…

North AmericaPfizerPharmaceuticalPrevnarRegulationVaccines

US FDA backs SC form of B-MS Orencia; extends review of Pfizer’s Prevnar 13

01-08-2011

The US Food and Drug Administration has approved a subcutaneous (SC) formulation of drug major Bristol-Myers…

Anti-Arthritics/RheumaticsBristol-Myers SquibbNorth AmericaOrenciaPfizerPharmaceuticalPrevnarRegulationVaccines

European Medicines Agency updates on pioglitazone, Pandemrix and Champix

22-07-2011

Yesterday saw a batch of recommendations from the European Medicines Agency’s advisory body, including…

ActosChampixDiabetesEuropeGlaxoSmithKlineNeurologicalPandemrixPfizerPharmaceuticalRegulationTakeda PharmaceuticalsVaccines

Back to top